HeartSine Technologies is recalling 12 samaritan Public Access Defibrillators (PAD) because they were shipped in a test configuration rather than a clinical one. This defect causes the devices to provide incorrect instructions, such as prompting users to perform CPR for only 5 seconds and attempting to deliver shocks every 5 seconds if a shockable rhythm is found. These devices were distributed worldwide, including in Texas, California, Illinois, Colorado, Florida, North Carolina, and Michigan. Consumers should contact the manufacturer immediately to resolve this issue as the device may not provide life-saving therapy during a cardiac emergency.
The device may provide incorrect voice and visual prompts, leading to significantly shortened CPR cycles and rapid shock analysis. This can result in the patient receiving no therapy or delayed therapy during a life-threatening cardiac event.
Corrective configuration update or manufacturer instructions
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.